TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
230,446,545
|
183,839,932
|
156,304,502 |
| Financial expenses |
1,590,261
|
550,076
|
1,440,625 |
| Earnings before taxes |
65,991,703
|
83,833,440
|
-19,544,448 |
| EBITDA |
46,316,607
|
42,264,697
|
27,952,665 |
| Total assets |
460,781,710
|
370,015,915
|
255,456,014 |
| Current assets |
66,586,762
|
37,700,989
|
31,933,066 |
| Current liabilities |
41,147,743
|
24,589,319
|
23,601,467 |
| Equity capital |
368,997,687
|
314,597,711
|
200,068,287 |
| - share capital |
2,118,285
|
2,080,767
|
1,942,905 |
| Employees (average) |
7,543
|
7,248
|
6,875 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
80.1%
|
85.0%
|
78.3% |
| Turnover per employee |
30,551
|
25,364
|
22,735 |
| Profit as a percentage of turnover |
28.6%
|
45.6%
|
-12.5% |
| Return on assets (ROA) |
14.7%
|
22.8%
|
-7.1% |
| Current ratio |
161.8%
|
153.3%
|
135.3% |
| Return on equity (ROE) |
17.9%
|
26.6%
|
-9.8% |
| Change turnover |
43,291,811
|
16,444,544
|
48,410,865 |
| Change turnover % |
23%
|
10%
|
45% |
| Chg. No. of employees |
295
|
373
|
61 |
| Chg. No. of employees % |
4%
|
5%
|
1% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.